| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |